CMS Lets Part D Plans Waive Costs For Drugs That Treat COVID-19

Part D plans may waive costs for drugs that treat COVID-19, even if those waivers are inconsistent with the bid and plan benefit package, according to a May 22 update to Medicare coronavirus guidance . This waiver takes effect immediately and lasts through at least this plan year, unless HHS lifts the public health emergency. The agency will also allow Part D plans to waive cost-sharing for covered drugs that could treat COVID-19 when submitting their 2021 bid, unless HHS...